Anastasia A. Kochneva
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Anastasia A. Kochneva has a total of 18 co-authors. Here are the top co-authors by number of shared publications:
- Aleksandr A. Moshchenko
Federal Center of Brain Research and Neurotechnologies, Federal Medical Biological Agency, Moscow, Russia
1 shared publication - Aleksey N. Ikrin
Department of Neurobiology, Scientific Center of Genetics and Life Sciences, Sirius University of Science and Technology, Federal Territory of Sirius, 354340 Sochi, Russia
1 shared publication - Aleksey V. Yakovlev
Department of Human and Animal Physiology, Institute of Fundamental Medicine and Biology, Kazan Federal University, 420012 Kazan, Russia
1 shared publication - Andrei M. Karhov
M.M. Shemyakin and Yu.A. Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences, Moscow 117997, Russia
1 shared publication - Dmitry S. Bilan
M.M. Shemyakin and Yu.A. Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences, Moscow, Russia
1 shared publication - Elena V. Gerasimova
Department of Neuroscience, Sirius University of Science and Technology, Sochi, Russia
1 shared publication
Latest Publications
- Open Access
- 19 December 2025
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 27 (1) , 26
Neuroinflammatory and Redox Responses in a Rat Model of NTG-Induced Migraine
Neuroinflammation is a common pathophysiological feature of many disorders affecting the central nervous system, including migraine—one of the most prevalent neurological conditions, which significantly impairs quality of life, particularly when it progresses to the chronic form. The aim of the present study was to analyze oxidative changes following a single administration of nitroglycerin (NTG), as well as to investigate alterations in the glial microenvironment and inflammatory processes induced by chronic NTG administration. Registration of biosensor signals (HyPer7 and SypHer3s) in vivo did not reveal changes in hydrogen peroxide levels or pH following single NTG administration in striatum and cortex. In contrast, analysis of chronic NTG administration indicates neuroinflammatory processes occurring in the thalamus and the dentate gyrus of the hippocampus, but not in the somatosensory cortex without disruption of the BBB and decreased degranulation of meningeal mast cells. We observed a decrease in the mRNA expression in the thalamic tissue of the neuroprotective transforming growth factor beta 1 gene and an increase in the expression of the pro-inflammatory interferon gamma. The regional specificity of neuroinflammation supports the suggestion that maladaptive changes in these structures could play a critical role in the transition from episodic to chronic migraine.
- 19 December 2025
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 27 (1) , 26
Open AccessNeuroinflammatory and Redox Responses in a Rat Model of NTG-Induced Migraine
Neuroinflammation is a common pathophysiological feature of many disorders affecting the central nervous system, including migraine—one of the most prevalent neurological conditions, which significantly impairs quality of life, particularly when it progresses to the chronic form. The aim of the present study was to analyze oxidative changes following a single administration of nitroglycerin (NTG), as well as to investigate alterations in the glial microenvironment and inflammatory processes induced by chronic NTG administration. Registration of biosensor signals (HyPer7 and SypHer3s) in vivo did not reveal changes in hydrogen peroxide levels or pH following single NTG administration in striatum and cortex. In contrast, analysis of chronic NTG administration indicates neuroinflammatory processes occurring in the thalamus and the dentate gyrus of the hippocampus, but not in the somatosensory cortex without disruption of the BBB and decreased degranulation of meningeal mast cells. We observed a decrease in the mRNA expression in the thalamic tissue of the neuroprotective transforming growth factor beta 1 gene and an increase in the expression of the pro-inflammatory interferon gamma. The regional specificity of neuroinflammation supports the suggestion that maladaptive changes in these structures could play a critical role in the transition from episodic to chronic migraine.